Kana Tanahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kana Tanahashi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Akiyama
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
8 shared publications - Takuya Takeichi
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
7 shared publications - Yoshinao Muro
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
5 shared publications - Akio Kihara
Faculty of Pharmaceutical Sciences Hokkaido University Sapporo Japan
2 shared publications - Michihiro Kono
Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan
2 shared publications - Yuika Suzuki
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
2 shared publications
Latest Publications
- 11 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (1) , 149-154
Susceptibility to Dermatophytosis in SDR9C7 ‐Nonsyndromic Epidermal Differentiation Disorder: Observation of Cutaneous Inflammation Involving IRF4 and IL ‐17
SDR9C7 ‐nonsyndromic epidermal differentiation disorder (nEDD) is a form of ceramide synthesis disorder that is known to confer susceptibility to dermatophytosis. Recurrent widespread tinea corporis developed in a SDR9C7 ‐nEDD patient with homozygosity for the Japanese founder variant (c.826C>T, p.Arg276Cys) during apremilast treatment to improve ectropion. Ceramide analysis of the stratum corneum revealed decreased protein‐bound ceramides, indicating skin barrier dysfunction. Based on previous studies of decreased Irf4 mRNA in Sdr9c7 −/− mice, IRF4 transcription factor‐dependent IL‐17 production, and the importance of IL‐17A/F in mucocutaneous immunity against Candida albicans , we examined the expression of each molecule using immunofluorescence and found for the first time decreased IRF4 and IL17‐A/C/F (which were further decreased by apremilast treatment) in SDR9C7 ‐nEDD epidermis. Although further studies are needed to clarify an evaluation of cytokine profiles in SDR9C7 ‐nEDD, which may have immune profiles different from the previously reported IL‐17‐dominant immune profiles in the major forms of ichthyosis, these findings might have contributed to susceptibility to dermatophytosis in this patient, and it is suggested that the use of apremilast should be avoided in SDR9C7 ‐nEDD.
- 11 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (1) , 149-154
Susceptibility to Dermatophytosis in SDR9C7 ‐Nonsyndromic Epidermal Differentiation Disorder: Observation of Cutaneous Inflammation Involving IRF4 and IL ‐17
SDR9C7 ‐nonsyndromic epidermal differentiation disorder (nEDD) is a form of ceramide synthesis disorder that is known to confer susceptibility to dermatophytosis. Recurrent widespread tinea corporis developed in a SDR9C7 ‐nEDD patient with homozygosity for the Japanese founder variant (c.826C>T, p.Arg276Cys) during apremilast treatment to improve ectropion. Ceramide analysis of the stratum corneum revealed decreased protein‐bound ceramides, indicating skin barrier dysfunction. Based on previous studies of decreased Irf4 mRNA in Sdr9c7 −/− mice, IRF4 transcription factor‐dependent IL‐17 production, and the importance of IL‐17A/F in mucocutaneous immunity against Candida albicans , we examined the expression of each molecule using immunofluorescence and found for the first time decreased IRF4 and IL17‐A/C/F (which were further decreased by apremilast treatment) in SDR9C7 ‐nEDD epidermis. Although further studies are needed to clarify an evaluation of cytokine profiles in SDR9C7 ‐nEDD, which may have immune profiles different from the previously reported IL‐17‐dominant immune profiles in the major forms of ichthyosis, these findings might have contributed to susceptibility to dermatophytosis in this patient, and it is suggested that the use of apremilast should be avoided in SDR9C7 ‐nEDD.
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1470-1474
A Cross‐Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career
A cross‐sectional analysis was conducted to evaluate the impact of ichthyosis symptoms on the educational achievement and career choices of adults, or the potential future impact on children. A total of 77 respondents completed a questionnaire assessing the degree to which ichthyosis had impacted, or was expected to impact, their education and career. Responses were categorized as “none,” “somewhat,” or “greatly.” The data were analyzed in relation to the objective severity measures in our previous study, including the Clinical Ichthyosis Score (CIS) and QOL assessments, using Spearman's correlation coefficients. Of the 77 participants, 45.5% reported a great impact, 41.6% reported some impact, and 13.0% reported no impact. A significant positive correlation was observed between the perceived impact and CIS (rs = 0.402, p < 0.001), as well as between the perceived impact and QOL scores (16 ≤ age, rs = 0.462, p < 0.001; 4 ≤ age ≤ 15, rs = 0.822, p < 0.001; age ≤ 3, rs = 0.894, p = 0.106). Symptoms such as itching, pain, and social discomfort were identified as potential cumulative contributors to educational and occupational limitations. The findings suggest that higher disease severity and lower QOL are significantly associated with adverse educational and career outcomes in patients with congenital ichthyosis. (207/300 words).
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1470-1474
A Cross‐Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career
A cross‐sectional analysis was conducted to evaluate the impact of ichthyosis symptoms on the educational achievement and career choices of adults, or the potential future impact on children. A total of 77 respondents completed a questionnaire assessing the degree to which ichthyosis had impacted, or was expected to impact, their education and career. Responses were categorized as “none,” “somewhat,” or “greatly.” The data were analyzed in relation to the objective severity measures in our previous study, including the Clinical Ichthyosis Score (CIS) and QOL assessments, using Spearman's correlation coefficients. Of the 77 participants, 45.5% reported a great impact, 41.6% reported some impact, and 13.0% reported no impact. A significant positive correlation was observed between the perceived impact and CIS (rs = 0.402, p < 0.001), as well as between the perceived impact and QOL scores (16 ≤ age, rs = 0.462, p < 0.001; 4 ≤ age ≤ 15, rs = 0.822, p < 0.001; age ≤ 3, rs = 0.894, p = 0.106). Symptoms such as itching, pain, and social discomfort were identified as potential cumulative contributors to educational and occupational limitations. The findings suggest that higher disease severity and lower QOL are significantly associated with adverse educational and career outcomes in patients with congenital ichthyosis. (207/300 words).
- 23 June 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (6) , e70130
The First Reported Japanese Case of PNPLA1‐Nonsyndromic Epidermal Differentiation Disorder (PNPLA1‐nEDD) Associated With an Unreported 92‐Base‐Pair Duplication Variant
Autosomal recessive congenital ichthyosis (ARCI) is a rare inherited skin disorder marked by generalised scaling and erythema. Very recently, diseases formerly diagnosed as ichthyosis, including ARCI, have been renamed nonsyndromic epidermal differentiation disorders (nEDDs). Although pathogenic variants in various genes, including PNPLA1, have been identified as causes, regional and ethnic differences exist in their prevalence. PNPLA1 encodes a unique transacylase essential for acylceramide synthesis, a critical component of the skin barrier. Here, we describe the first reported Japanese case of a PNPLA1‐related nonsyndromic epidermal differentiation disorder (PNPLA1‐nEDD) caused by a homozygous 92‐base‐pair duplication variant (c.36_127dup, p.Leu43Profs*46) in PNPLA1. Lipidomic analysis of the stratum corneum revealed marked reductions in ω‐O‐acylceramides and protein‐bound ceramides, alongside the accumulation of non‐acylated ceramides—indicating a failure in acylceramide synthesis. This ceramide profile supports the conclusion that the PNPLA1 duplication causes a loss of function. Our findings emphasise the importance of PNPLA1 in the genetic screening of nEDD cases in Japan, regardless of clinical subtype, due to the absence of genotype–phenotype correlations and to broad phenotypic variability.
- 23 June 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (6) , e70130
The First Reported Japanese Case of PNPLA1‐Nonsyndromic Epidermal Differentiation Disorder (PNPLA1‐nEDD) Associated With an Unreported 92‐Base‐Pair Duplication Variant
Autosomal recessive congenital ichthyosis (ARCI) is a rare inherited skin disorder marked by generalised scaling and erythema. Very recently, diseases formerly diagnosed as ichthyosis, including ARCI, have been renamed nonsyndromic epidermal differentiation disorders (nEDDs). Although pathogenic variants in various genes, including PNPLA1, have been identified as causes, regional and ethnic differences exist in their prevalence. PNPLA1 encodes a unique transacylase essential for acylceramide synthesis, a critical component of the skin barrier. Here, we describe the first reported Japanese case of a PNPLA1‐related nonsyndromic epidermal differentiation disorder (PNPLA1‐nEDD) caused by a homozygous 92‐base‐pair duplication variant (c.36_127dup, p.Leu43Profs*46) in PNPLA1. Lipidomic analysis of the stratum corneum revealed marked reductions in ω‐O‐acylceramides and protein‐bound ceramides, alongside the accumulation of non‐acylated ceramides—indicating a failure in acylceramide synthesis. This ceramide profile supports the conclusion that the PNPLA1 duplication causes a loss of function. Our findings emphasise the importance of PNPLA1 in the genetic screening of nEDD cases in Japan, regardless of clinical subtype, due to the absence of genotype–phenotype correlations and to broad phenotypic variability.
- 19 March 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6) , e578-e579
Cutaneous inflammation with upregulated interleukin‐36γ and TNFα in a patient with loricrin keratoderma
- 19 March 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6) , e578-e579
Cutaneous inflammation with upregulated interleukin‐36γ and TNFα in a patient with loricrin keratoderma
- 23 December 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (4)
Protruding nodular fasciitis on the face
- 23 December 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (4)
Protruding nodular fasciitis on the face
- Open Access
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7791
Deep Phenotyping of Superficial Epidermolytic Ichthyosis due to a Recurrent Mutation in KRT2
Superficial epidermolytic ichthyosis (SEI) is an autosomal dominant inherited ichthyosis. SEI is caused by mutations in KRT2 and frequently shows erythroderma and widespread blistering at birth. We report the clinical manifestations of two patients from a Japanese family with SEI caused by a hotspot mutation, p.Glu487Lys, in KRT2. In addition, we summarize previous reports on SEI patients with the identical mutation. One of the two patients had disease onset at the age of 7 months. The other patient’s age of onset is unknown, but it was in childhood. Neither of the two patients showed erythroderma. To perform deep phenotyping, we studied the age of onset and the frequency of erythroderma in 34 reported SEI cases with the p.Glu487Lys mutation, including the present cases. Among the cases with sufficient clinical information, 44.4% of the cases that were due to p.Glu487Lys in KRT2 occurred at birth. Erythroderma was observed in 11.1% of the cases with p.Glu487Lys in KRT2.
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7791
Open AccessDeep Phenotyping of Superficial Epidermolytic Ichthyosis due to a Recurrent Mutation in KRT2
Superficial epidermolytic ichthyosis (SEI) is an autosomal dominant inherited ichthyosis. SEI is caused by mutations in KRT2 and frequently shows erythroderma and widespread blistering at birth. We report the clinical manifestations of two patients from a Japanese family with SEI caused by a hotspot mutation, p.Glu487Lys, in KRT2. In addition, we summarize previous reports on SEI patients with the identical mutation. One of the two patients had disease onset at the age of 7 months. The other patient’s age of onset is unknown, but it was in childhood. Neither of the two patients showed erythroderma. To perform deep phenotyping, we studied the age of onset and the frequency of erythroderma in 34 reported SEI cases with the p.Glu487Lys mutation, including the present cases. Among the cases with sufficient clinical information, 44.4% of the cases that were due to p.Glu487Lys in KRT2 occurred at birth. Erythroderma was observed in 11.1% of the cases with p.Glu487Lys in KRT2.
- Open Access
Frequent FOXA1-Activating Mutations in Extramammary Paget’s Disease
Extramammary Paget’s disease (EMPD) is a neoplastic skin disease of indeterminate origin with an unknown genetic cause. We performed a comprehensive genetic analysis or targeted gene sequencing in 48 patients with EMPD. We identified FOXA1 mutations, a GAS6–FOXA1 fusion gene, and somatic hotspot mutations in the FOXA1 promoter region in 11 of the 48 EMPD patients (11/48, 23%). Additional mutations were identified in PIK3CA (six patients) and in HIST1H2BB, HIST1H2BC, and SMARCB1 (one patient each), but none were found in other frequently mutated genes in cancer. A global gene expression analysis using EMPD clinical samples found the upregulation of PI3 kinase–AKT–mTOR signaling. ABCC11, which is specifically expressed in the apocrine secretory cells and is necessary for their sweat secretion, was upregulated in the EMPD samples. This upregulation suggests that Paget cells originate from apocrine secretory cells. Immunohistochemical staining revealed that FOXA1 expression was prevalent in all of the EMPD samples analyzed and was associated with estrogen receptor expression. Our genetic analysis indicates that EMPD frequently involves FOXA1 mutations. FOXA1 is a transcriptional pioneer factor for the estrogen receptor, and the present results suggest that certain treatments for hormone-dependent cancers could be effective for EMPD.
Open AccessFrequent FOXA1-Activating Mutations in Extramammary Paget’s Disease
Extramammary Paget’s disease (EMPD) is a neoplastic skin disease of indeterminate origin with an unknown genetic cause. We performed a comprehensive genetic analysis or targeted gene sequencing in 48 patients with EMPD. We identified FOXA1 mutations, a GAS6–FOXA1 fusion gene, and somatic hotspot mutations in the FOXA1 promoter region in 11 of the 48 EMPD patients (11/48, 23%). Additional mutations were identified in PIK3CA (six patients) and in HIST1H2BB, HIST1H2BC, and SMARCB1 (one patient each), but none were found in other frequently mutated genes in cancer. A global gene expression analysis using EMPD clinical samples found the upregulation of PI3 kinase–AKT–mTOR signaling. ABCC11, which is specifically expressed in the apocrine secretory cells and is necessary for their sweat secretion, was upregulated in the EMPD samples. This upregulation suggests that Paget cells originate from apocrine secretory cells. Immunohistochemical staining revealed that FOXA1 expression was prevalent in all of the EMPD samples analyzed and was associated with estrogen receptor expression. Our genetic analysis indicates that EMPD frequently involves FOXA1 mutations. FOXA1 is a transcriptional pioneer factor for the estrogen receptor, and the present results suggest that certain treatments for hormone-dependent cancers could be effective for EMPD.
- 3 February 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (2) , 890-903
SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation
The corneocyte lipid envelope, composed of covalently bound ceramides and fatty acids, is important to the integrity of the permeability barrier in the stratum corneum, and its absence is a prime structural defect in various skin diseases associated with defective skin barrier function. SDR9C7 encodes a short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) recently found mutated in ichthyosis. In a patient with SDR9C7 mutation and a mouse Sdr9c7-KO model, we show loss of covalent binding of epidermal ceramides to protein, a structural fault in the barrier. For reasons unresolved, protein binding requires lipoxygenase-catalyzed transformations of linoleic acid (18:2) esterified in ω-O-acylceramides. In Sdr9c7–/– epidermis, quantitative liquid chromatography–mass spectometry (LC-MS) assays revealed almost complete loss of a species of ω-O-acylceramide esterified with linoleate-9,10-trans-epoxy-11E-13-ketone; other acylceramides related to the lipoxygenase pathway were in higher abundance. Recombinant SDR9C7 catalyzed NAD+-dependent dehydrogenation of linoleate 9,10-trans-epoxy-11E-13-alcohol to the corresponding 13-ketone, while ichthyosis mutants were inactive. We propose, therefore, that the critical requirement for lipoxygenases and SDR9C7 is in producing acylceramide containing the 9,10-epoxy-11E-13-ketone, a reactive moiety known for its nonenzymatic coupling to protein. This suggests a mechanism for coupling of ceramide to protein and provides important insights into skin barrier formation and pathogenesis.
- 3 February 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (2) , 890-903
SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation
The corneocyte lipid envelope, composed of covalently bound ceramides and fatty acids, is important to the integrity of the permeability barrier in the stratum corneum, and its absence is a prime structural defect in various skin diseases associated with defective skin barrier function. SDR9C7 encodes a short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) recently found mutated in ichthyosis. In a patient with SDR9C7 mutation and a mouse Sdr9c7-KO model, we show loss of covalent binding of epidermal ceramides to protein, a structural fault in the barrier. For reasons unresolved, protein binding requires lipoxygenase-catalyzed transformations of linoleic acid (18:2) esterified in ω-O-acylceramides. In Sdr9c7–/– epidermis, quantitative liquid chromatography–mass spectometry (LC-MS) assays revealed almost complete loss of a species of ω-O-acylceramide esterified with linoleate-9,10-trans-epoxy-11E-13-ketone; other acylceramides related to the lipoxygenase pathway were in higher abundance. Recombinant SDR9C7 catalyzed NAD+-dependent dehydrogenation of linoleate 9,10-trans-epoxy-11E-13-alcohol to the corresponding 13-ketone, while ichthyosis mutants were inactive. We propose, therefore, that the critical requirement for lipoxygenases and SDR9C7 is in producing acylceramide containing the 9,10-epoxy-11E-13-ketone, a reactive moiety known for its nonenzymatic coupling to protein. This suggests a mechanism for coupling of ceramide to protein and provides important insights into skin barrier formation and pathogenesis.